AltPep Raises $23M Jumpstarting Work on Alzheimer's Disease
AltPep Raises $23M Jumpstarting Work on Alzheimers Disease Search jobs SEATTLE - January 14, 2021 - (Newswire.com) AltPep Corporation, a privately held biomedical company focused on diagnosing and treating Central Nervous System amyloid disorders, starting with Alzheimers Disease, today announced it closed a $23.150 million Series A investment round. Matrix Capital Management led the investment, with significant participation by Alexandria Venture Investments. In conjunction...
Source: pharmiweb.com